Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Amgen.

Advances In™: Multiple Myeloma: Updates in the Prevention of Skeletal-Related Events

Release Date: August 30, 2019
Expiration Date: August 30, 2020
Media: Internet - based

Activity Overview

This Advances In™ program aims to update you on the latest information on the management of skeletal-related events in multiple myeloma (MM). Patients with MM are particularly susceptible to bone involvement, and the majority of patients have some evidence or symptom of bone disease at presentation. This combined text and video format provide the opportunity to become up-to-date with the latest information regarding techniques and strategies for the monitoring, diagnosis, and treatment of bone disease. The expert faculty provide their perspectives on how the latest data fit into the treatment paradigm for MM, and a look toward the future of research and treatment for bone disease in MM.

Benefits of Participating

  • Learn about recent data regarding systemic treatment options for bone disease and skeletal-related events (SREs) in MM
  • Hear expert perspectives on how to incorporate recent data into the plan of care for your patients with MM
  • Identify ongoing areas of research with the potential to impact the management of SREs in MM in the near future

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Amgen.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Target Audience

This educational program is directed toward medical oncologists and hematologists who treat patients with MM. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of MM are also invited to participate in the activity.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Describe the impact of skeletal-related events (SREs) in the context of MM
  • Identify strategies to diagnose and proactively monitor ongoing SREs or prevent bone complications during cancer treatment in patients with MM
  • Select appropriate therapy for the prevention of SREs in patients with MM
  • Integrate recent clinical trial evidence for the prevention and mitigation of SREs in patients with MM

Faculty, Staff, and Planners’ Disclosures


Noopur Raje, MD
Noopur Raje, MD
Professor of Medicine
Harvard Medical School
Director, Multiple Myeloma Center
Massachusetts General Hospital
Boston, MA

Disclosures: Consultant: Amgen, Bristol-Myers Squibb, Celgene, Janssen, Takeda

Jens Hillengass, MD
Jens Hillengass, MD
Professor of Oncology, Chief of Myeloma, Department of Medicine
Roswell Park Comprehensive Cancer Center
Professor of Medicine, Division of Hematology and Oncology
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo
Buffalo, NY

Disclosures: Grant/Research Support: Celgene; Honoraria (for Talk/Advisory Board): Janssen, Amgen

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or the companies that provided commercial support for this program.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By